Thor Halfdanarson: What’s on My NET PubMed Radar
Thor Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared on X about a recent paper shared by Rohit Thummalapalli et al. published in MedRxiv:
“On my NET PubMed radar this morning from Rohit Thummalapalli et al. at MSKCC. DLL3 positive in 71% of GEPNECs and 43% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out!”
Title: Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms
Authors: Rohit Thummalapalli, Salomon Tendler, Joanne F. Chou, Zeynep C. Tarcan, Courtney Porfido, Jonathan Willner, Irina Linkov, Umesh Bhanot, Alissa J. Cooper, Jierui Xu, James J. Harding, Natasha Rekhtman, Laura H. Tang, Charles M. Rudin, Yelena Y. Janjigian, Heiko Schöder, John T. Porier, Jinru Shia, Olca Basturk, Diane Reidy-Lagunes, Marinela Capanu, Jason S. Lewis, Lisa Bodei, Mark P. Dunphy, Nitya Raj
More posts featuring Thor Halfdanarson.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023